🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
10.52
-0.74 (-6.57%)
Nov 20, 2026, 4:00 PM EST - Market closed

ArriVent BioPharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
34.9724.1815.39.716.473.02
Research & Development
153.35153.357964.8830.438.58
Operating Expenses
188.32177.5394.3174.5936.9111.59
Operating Income
-181-177.53-94.31-74.59-36.91-11.59
Interest & Investment Income
11.9311.2313.825.26--
EBT Excluding Unusual Items
-169.07-166.31-80.49-69.33-36.91-11.59
Pretax Income
-169.97-166.31-80.49-69.33-36.91-68.81
Net Income
-169.97-166.31-80.49-69.33-36.91-68.81
Net Income to Common
-169.97-166.31-80.49-69.33-36.91-68.81
Net Income Growth
------
Shares Outstanding (Basic)
463831211
Shares Outstanding (Diluted)
463831211
Shares Change
28.07%22.22%1369.88%67.64%79.57%-
EPS (Basic)
-3.67-4.32-2.56-32.38-28.90-96.75
EPS (Diluted)
-3.67-4.32-2.56-32.38-28.90-96.75
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EBIT
-181-177.53-94.31-74.59-36.91-11.59
SEC Filings: 10-K · 10-Q